TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24885096

Group type: EXPERIMENTAL
Intervention: Counselling protocol with the It's LiFe! tool (group 1)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Counselling protocol without the It's LiFe! tool (group 2)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Usual care (group 3)
Number of subjects: 240
Study: 22450480

Group type: EXPERIMENTAL
Intervention: Postoperative cognitive assessment after carotid endarterectomy (CEA)
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Neuropsychological testing before and after surgery
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Receiver operating characteristic analysis for neuropsychological test scores
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Neuropsychological test scores exceeding cut-off points
Number of subjects: 213
Study: 19903661

Group type: EXPERIMENTAL
Intervention: Enalapril 20 mg o.d. and Candesartan 16 mg o.d. (combined treatment)
Number of subjects: 47
Study: 22433042

Group type: EXPERIMENTAL
Intervention: Creatine (Cr) supplementation (5 g 4/day for days 1-7; 2.5 g 2/day for days 8-14)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Creatine (Cr) supplementation
Number of subjects: 11
Study: 15654537

Group type: EXPERIMENTAL
Intervention: Influenza vaccination in 2002/2003 season
Number of subjects: 4011

Group type: EXPERIMENTAL
Intervention: Influenza vaccination in 2003/2004 season
Number of subjects: 4011

Group type: EXPERIMENTAL
Intervention: Reasons for being vaccinated
Number of subjects: 4011

Group type: EXPERIMENTAL
Intervention: Reasons for not being vaccinated
Number of subjects: 4011

Group type: EXPERIMENTAL
Intervention: Options encouraging vaccination
Number of subjects: 4011
Study: 12460817

Group type: EXPERIMENTAL
Intervention: Professional cleaning of homes
Number of subjects: 765

Group type: EXPERIMENTAL
Intervention: Professional cleaning of homes (for homes with precleaning dust lead levels above recommended clearance levels)
Number of subjects: 765
Study: 10610644

Group type: EXPERIMENTAL
Intervention: Alendronate 5 mg/d
Number of subjects: 1609

Group type: EXPERIMENTAL
Intervention: Alendronate 2.5 mg/d
Number of subjects: 1609

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1609

Group type: EXPERIMENTAL
Intervention: Estrogen-progestin (open-label)
Number of subjects: 1609
Study: 8738773

Group type: EXPERIMENTAL
Intervention: Lithium heparin containers
Number of subjects: 25

Group type: COMPARATOR
Intervention: Sodium edetate containers
Number of subjects: 25
Study: 1879192

Group type: EXPERIMENTAL
Intervention: 5 mg/kg b.i.d. for 7 consecutive days
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: 10 mg/kg b.i.d. for 7 consecutive days
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: 10 mg/kg b.i.d. for 3 consecutive days
Number of subjects: 131
Study: 7104133

Group type: EXPERIMENTAL
Intervention: 0.25% bupivacaine 10 ml
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 2% 2-chloroprocaine 10 ml
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Combined extradural groups
Number of subjects: 26

Group type: COMPARATOR
Intervention: Non-extradural control group
Number of subjects: 26
Study: 30778597

Group type: EXPERIMENTAL
Intervention: IV acetaminophen
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 120

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 120
Study: 28359862

Group type: EXPERIMENTAL
Intervention: Ketamine (0.5 mg/kg intravenous bolus)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 79
Study: 25268924

Group type: EXPERIMENTAL
Intervention: Sleep 101 program (experimental condition)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sleep monitoring (control condition)
Number of subjects: 0
Study: 25052018

Group type: EXPERIMENTAL
Intervention: Proposed back-extrapolation method
Number of subjects: 36

Group type: COMPARATOR
Intervention: Traditional back-extrapolation method
Number of subjects: 36
Study: 21940091

Group type: EXPERIMENTAL
Intervention: 2 mL of 2% lidocaine with clonidine (15 μg/mL)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Lidocaine with epinephrine (12.5 μg/mL)
Number of subjects: 50
Study: 18602820

Group type: EXPERIMENTAL
Intervention: Isoflavone tablets at 144 mg/day
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Isoflavone tablets at 288 mg/day
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Soy foods providing 96 mg isoflavones/day
Number of subjects: 12
Study: 17130246

Group type: EXPERIMENTAL
Intervention: Direct superior approach
Number of subjects: 38

Group type: COMPARATOR
Intervention: Indirect subacromial approach
Number of subjects: 38
Study: 16337447

Group type: EXPERIMENTAL
Intervention: Ciclesonide 80 microg once daily
Number of subjects: 1015

Group type: EXPERIMENTAL
Intervention: Ciclesonide 160 microg once daily
Number of subjects: 1015

Group type: EXPERIMENTAL
Intervention: Ciclesonide 320 microg once daily
Number of subjects: 1015

Group type: EXPERIMENTAL
Intervention: Ciclesonide (all doses)
Number of subjects: 1015

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1015
Study: 12459865

Group type: EXPERIMENTAL
Intervention: Cerivastatin (0.4 mg/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cerivastatin (0.4 mg/day) + Antioxidant probucol (250 mg/day)
Number of subjects: 0
Study: 9594938

Group type: EXPERIMENTAL
Intervention: Terbinafine
Number of subjects: 92

Group type: COMPARATOR
Intervention: Itraconazole
Number of subjects: 92
Study: 7705385

Group type: EXPERIMENTAL
Intervention: Low salt intake (20 mmol d‐1) for 3 days
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: High salt intake (200 mmol d‐1) for 3 days
Number of subjects: 14

Group type: COMPARATOR
Intervention: Low salt intake (20 mmol d‐1) for 7 days
Number of subjects: 14

Group type: COMPARATOR
Intervention: High salt intake (200 mmol d‐1) for 7 days
Number of subjects: 14
Study: 1514166

Group type: EXPERIMENTAL
Intervention: Combined low dose aspirin (75 mg) and low intensity anticoagulation (INR 1.5)
Number of subjects: 3667

Group type: EXPERIMENTAL
Intervention: Low intensity anticoagulation alone (W)
Number of subjects: 3667

Group type: EXPERIMENTAL
Intervention: Low dose aspirin alone (A)
Number of subjects: 3667

Group type: COMPARATOR
Intervention: Double placebo treatment (P)
Number of subjects: 3667

Group type: EXPERIMENTAL
Intervention: Combined low dose aspirin and low intensity anticoagulation (WA)
Number of subjects: 3667

Group type: EXPERIMENTAL
Intervention: Low intensity anticoagulation (W)
Number of subjects: 3667

Group type: EXPERIMENTAL
Intervention: Low dose aspirin (A)
Number of subjects: 3667
Study: 6504946

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (600 mg to 1400 mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 31658028

Group type: EXPERIMENTAL
Intervention: Application of resin-based surface sealants (SSs)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Exposure to artificial UV light
Number of subjects: 30

Group type: COMPARATOR
Intervention: Mechanically finished and polished surfaces
Number of subjects: 30
Study: 29554027

Group type: EXPERIMENTAL
Intervention: 15.0-mm scleral lens
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: 18.0-mm scleral lens
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: 18.2-mm scleral lens
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: All lens designs
Number of subjects: 35
Study: 27253768

Group type: COMPARATOR
Intervention: 5 hours of time in bed (TIB) for sleep each night
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: 9 hours of time in bed (TIB) for sleep each night
Number of subjects: 56
Study: 24902475

Group type: EXPERIMENTAL
Intervention: Preexisting psychiatric disorders (substance abuse, psychosis, bipolar disorder, schizophrenia, depression)
Number of subjects: 2005

Group type: EXPERIMENTAL
Intervention: Neurologic conditions (cerebrovascular disease, dementia, traumatic brain injury, brain tumor, metastatic cancer)
Number of subjects: 2005

Group type: EXPERIMENTAL
Intervention: Substance abuse/dependence
Number of subjects: 2005

Group type: EXPERIMENTAL
Intervention: Brain tumors
Number of subjects: 2005
Study: 22429229

Group type: EXPERIMENTAL
Intervention: Carbohydrate supplementation
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 20060192

Group type: EXPERIMENTAL
Intervention: Repaglinide (Rg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Glimepiride (Gm)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Gliclazide MR (Gli)
Number of subjects: 60
Study: 18036981

Group type: EXPERIMENTAL
Intervention: Standard analgesic care plus immersive VR distraction
Number of subjects: 88

Group type: COMPARATOR
Intervention: Standard analgesic care
Number of subjects: 88
Study: 15452689

Group type: EXPERIMENTAL
Intervention: Pamidronate (acute intravenous administration within 10 days of burn injury and again 1 week later)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Pamidronate (acute intravenous administration)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 43
Study: 11849315

Group type: EXPERIMENTAL
Intervention: Grass pollen immunotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 0
Study: 9408071

Group type: EXPERIMENTAL
Intervention: Metformin 850 mg b.i.d. (n = 10)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Metformin 500 mg b.i.d. (n = 10)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo b.i.d. (n = 5)
Number of subjects: 25
Study: 8010581

Group type: EXPERIMENTAL
Intervention: Perioperative administration of antibiotics
Number of subjects: 6069

Group type: EXPERIMENTAL
Intervention: Prolonged perioperative administration of antibiotics into the postoperative period
Number of subjects: 6069

Group type: COMPARATOR
Intervention: Multiple postoperative administrations of antibiotics
Number of subjects: 6069
Study: 3323851

Group type: EXPERIMENTAL
Intervention: Bellergal Retard (BR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 28438435

Group type: COMPARATOR
Intervention: Traditional physical therapy (PT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Home exercise (HE) program
Number of subjects: 60
Study: 27441418

Group type: EXPERIMENTAL
Intervention: Featback (8 weeks, no therapist support)
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Featback with low-intensity therapist support (weekly)
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Featback with high-intensity therapist support (three times a week)
Number of subjects: 354

Group type: COMPARATOR
Intervention: Waiting list
Number of subjects: 354
Study: 25275268

Group type: EXPERIMENTAL
Intervention: Training and Diet (TRD)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Training (TR)
Number of subjects: 20
Study: 22902987

Group type: EXPERIMENTAL
Intervention: 80 mg DAS infusion
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 160 mg DAS infusion
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 320 mg DAS infusion
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: All doses of DAS infusion
Number of subjects: 9
Study: 20406154

Group type: EXPERIMENTAL
Intervention: Walking to school daily
Number of subjects: 1362

Group type: EXPERIMENTAL
Intervention: Screen time more than two hours a day
Number of subjects: 1362

Group type: COMPARATOR
Intervention: Being driven to school daily
Number of subjects: 1362
Study: 18272560

Group type: EXPERIMENTAL
Intervention: Diagnostic lumbar selective nerve root block
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control level (adjacent asymptomatic)
Number of subjects: 47
Study: 15989936

Group type: EXPERIMENTAL
Intervention: Pursuit-rotor task
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Mirror tracing task
Number of subjects: 105

Group type: COMPARATOR
Intervention: Probabilistic classification task
Number of subjects: 105
Study: 12681875

Group type: EXPERIMENTAL
Intervention: Alendronate 35 mg once weekly
Number of subjects: 723

Group type: COMPARATOR
Intervention: Alendronate 5 mg daily
Number of subjects: 723
Study: 10872646

Group type: EXPERIMENTAL
Intervention: Amiodarone dosing regimen of 1600 mg/d for 2 days, 1200 mg/d for 5 days, 1000 mg/d for 7 days, 800 mg/d for 7 days, 600 mg/d for 7 days, and 400 mg/d for 62 days followed by a maintenance dose of 343 mg/d (400 mg/d for 6 of 7 days)
Number of subjects: 77
Study: 8864323

Group type: EXPERIMENTAL
Intervention: Calcium gluconate, 4 mg kg‐1 i.v. infusion during cisplatin therapy
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (no calcium supplementation)
Number of subjects: 22
Study: 1575068

Group type: EXPERIMENTAL
Intervention: Regular physical activity
Number of subjects: 75
Study: 2415098

Group type: EXPERIMENTAL
Intervention: Topical framycitin/gramicidin (Sofradex)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Oxytetracycline/hydrocortisone with polymyxin B (Terracortril)
Number of subjects: 55
Study: 30618196

Group type: EXPERIMENTAL
Intervention: Artery-preserving varicocelectomy (APV)
Number of subjects: 302

Group type: COMPARATOR
Intervention: Artery-ligating varicocelectomy (ALV)
Number of subjects: 302
Study: 29971784

Group type: EXPERIMENTAL
Intervention: Hand photography protocol for diagnosing hand dermatitis
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Subgroup analysis of 250 cases screened by a nurse
Number of subjects: 97
Study: 27940664

Group type: EXPERIMENTAL
Intervention: Inhaled laninamivir octanoate (20 mg)
Number of subjects: 343

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 343
Study: 25436803

Group type: EXPERIMENTAL
Intervention: LY2181308 (750 mg intravenously, weekly) plus docetaxel (75 mg/m intravenously, day 1)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Docetaxel alone (75 mg/m intravenously, every 21 days)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Combined arms (LY2181308/docetaxel and docetaxel)
Number of subjects: 162
Study: 23030357

Group type: EXPERIMENTAL
Intervention: 32-gauge × 4-mm pen needle
Number of subjects: 41

Group type: COMPARATOR
Intervention: 32-gauge × 6-mm pen needle
Number of subjects: 41
Study: 21041432

Group type: EXPERIMENTAL
Intervention: Dietary portfolio high in monounsaturated fat
Number of subjects: 24

Group type: COMPARATOR
Intervention: Dietary portfolio low in monounsaturated fat
Number of subjects: 24
Study: 18602082

Group type: EXPERIMENTAL
Intervention: Intermittent positive-pressure breathing (IPPB)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 14
Study: 15747590

Group type: EXPERIMENTAL
Intervention: Marginal proportional hazards model
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Data example from child vitamin A supplementation trial
Number of subjects: 0
Study: 12030960

Group type: EXPERIMENTAL
Intervention: Omeprazole (20 mg for 7 days)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Amoxicillin
Number of subjects: 54

Group type: COMPARATOR
Intervention: Ampicillin
Number of subjects: 54
Study: 9933263

Group type: EXPERIMENTAL
Intervention: High titers of antibodies to Chlamydia pneumoniae (IgA or IgG)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: High serum titer of antibodies to cytomegalovirus (CMV)
Number of subjects: 152
Study: 7763062

Group type: COMPARATOR
Intervention: Inhaled steroids
Number of subjects: 86
Study: 2276774

Group type: EXPERIMENTAL
Intervention: Prophylactic cimetidine (32 babies)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Cimetidine therapy (43 babies)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (68 babies for prophylactic study, 34 babies for treatment study)
Number of subjects: 100
Study: 361348

Group type: EXPERIMENTAL
Intervention: Carbenoxolone/alginate antacid combination
Number of subjects: 37

Group type: COMPARATOR
Intervention: Alginate antacid compound used alone
Number of subjects: 37
Study: 31359143

Group type: EXPERIMENTAL
Intervention: TNFi treatment
Number of subjects: 1455

Group type: COMPARATOR
Intervention: No TNFi treatment (Control)
Number of subjects: 1455
Study: 30874766

Group type: EXPERIMENTAL
Intervention: Catheter ablation
Number of subjects: 2204

Group type: COMPARATOR
Intervention: Drug therapy
Number of subjects: 2204
Study: 28002688

Group type: EXPERIMENTAL
Intervention: ocrelizumab (600 mg)
Number of subjects: 732

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 732
Study: 25846222

Group type: EXPERIMENTAL
Intervention: Murdoch Bowel Protocol(®)
Number of subjects: 331

Group type: COMPARATOR
Intervention: Routine bowel management (Control)
Number of subjects: 331
Study: 21924882

Group type: EXPERIMENTAL
Intervention: 4 g/d EPA + DHA
Number of subjects: 42
Study: 19681657

Group type: EXPERIMENTAL
Intervention: 36 g alcohol daily
Number of subjects: 13

Group type: COMPARATOR
Intervention: Non-alcoholic beverages
Number of subjects: 13
Study: 18458964

Group type: EXPERIMENTAL
Intervention: Low-energy laser (LEL) treatment as preventive treatment
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Low-energy laser (LEL) treatment as therapeutic intervention
Number of subjects: 62

Group type: COMPARATOR
Intervention: Sham illumination (control)
Number of subjects: 62
Study: 15830635

Group type: EXPERIMENTAL
Intervention: Silk sutures (4-0)
Number of subjects: 12

Group type: COMPARATOR
Intervention: ePTFE sutures (CV-5)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both suture materials
Number of subjects: 12
Study: 15072038

Group type: EXPERIMENTAL
Intervention: ST‐TENS (75 Hz)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: AL‐TENS (4 Hz)
Number of subjects: 33

Group type: COMPARATOR
Intervention: ST‐TENS and AL‐TENS
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: AL‐TENS
Number of subjects: 33
Study: 11085323

Group type: EXPERIMENTAL
Intervention: MDMA treatment
Number of subjects: 0
Study: 8905358

Group type: EXPERIMENTAL
Intervention: Aspiration lumpectomy
Number of subjects: 77

Group type: COMPARATOR
Intervention: Strip biopsy
Number of subjects: 77
Study: 1846451

Group type: EXPERIMENTAL
Intervention: Stapled uterine incision using the Stapler
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine uterine incision (control group)
Number of subjects: 0
Study: 6353434

Group type: EXPERIMENTAL
Intervention: 30 mg prazepam per day
Number of subjects: 2009

Group type: COMPARATOR
Intervention: 15 mg diazepam per day
Number of subjects: 2009

Group type: EXPERIMENTAL
Intervention: 30 mg prazepam (divided dosage)
Number of subjects: 2009

Group type: EXPERIMENTAL
Intervention: 30 mg prazepam (single night time dosage)
Number of subjects: 2009

Group type: COMPARATOR
Intervention: 15 mg diazepam (divided dosage)
Number of subjects: 2009
Study: 29779262

Group type: EXPERIMENTAL
Intervention: Salivary exRNA biomarkers (SPRR1A, lnc-TET3-2:1, FAM25A, CRCT1)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Salivary exRNA biomarkers
Number of subjects: 30
Study: 27198057

Group type: EXPERIMENTAL
Intervention: Peer-counseling intervention with a Navigator for up to 6 months
Number of subjects: 104

Group type: COMPARATOR
Intervention: No further intervention (Control group)
Number of subjects: 104
Study: 24714489

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (NaHCO3) infusion
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: NAC in combination with NaHCO3
Number of subjects: 720

Group type: COMPARATOR
Intervention: Hydration with sodium chloride infusion alone
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: Combined NAC and NaHCO3
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: NAC
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: NaHCO3
Number of subjects: 720

Group type: COMPARATOR
Intervention: Sodium chloride infusion alone
Number of subjects: 720
Study: 23970114

Group type: EXPERIMENTAL
Intervention: Inspiratory resistive loading at 30% of MIP
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Inspiratory resistive loading at 80% of MIP
Number of subjects: 25
Study: 21182457

Group type: EXPERIMENTAL
Intervention: V-5 Immunitor (V5) immunotherapy pill
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 19018197

Group type: EXPERIMENTAL
Intervention: Ultrasonic mist therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham device or alternative treatments
Number of subjects: 0
Study: 16763747

Group type: EXPERIMENTAL
Intervention: LKFibre diet (17-30 g/day fiber)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: LKFibre diet
Number of subjects: 18
Study: 14670885

Group type: EXPERIMENTAL
Intervention: Borage oil (920 mg gamma linolenic acid) - adults received four capsules twice daily, children received two capsules twice daily for 12 weeks.
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo - control group receiving placebo treatment for 12 weeks.
Number of subjects: 140
Study: 10999788

Group type: EXPERIMENTAL
Intervention: PTH-(1-34) 400 IU daily
Number of subjects: 23

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 23
Study: 8636808

Group type: EXPERIMENTAL
Intervention: Recombinant human growth hormone (rhGH) therapy
Number of subjects: 16
Study: 1512513

Group type: EXPERIMENTAL
Intervention: alpha-tocopherol (800 IU/day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study: 6381579

Group type: EXPERIMENTAL
Intervention: Cyaninoside chloride
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Heleniene
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 31
Study: 31395034

Group type: EXPERIMENTAL
Intervention: Voice and text messages
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interactive telephone-based counselling
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control arm (no additional phone-based support)
Number of subjects: 0
Study: 30012185

Group type: EXPERIMENTAL
Intervention: 200 mg of monomeric and oligomeric flavanols (MOF) daily for 3 months
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study: 26728060

Group type: EXPERIMENTAL
Intervention: Radiofrequency-based renal sympathetic denervation (RSD)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: RSD (in patients with exaggerated baseline exercise BP)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Sham (in patients with exaggerated baseline exercise BP)
Number of subjects: 71
Study: 24485734

Group type: EXPERIMENTAL
Intervention: Melaleuca alternifolia dental gel
Number of subjects: 34

Group type: COMPARATOR
Intervention: Colgate Total (Control)
Number of subjects: 34